Plaster for treating cervical vertebra/lumbar disease

Abstract

The invention discloses a medicinal plaster for treating neck and lumbar spine diseases, wherein each 120 plasters contain medicinal constituents prepared from the following raw materials (by weight ratio): safflower 18-23 parts, rhizome of Sichuan lovage 18-23 parts, frank incense 8-12 parts, myrrh 8-12 parts, radix aconiti 18-23 parts, Kusnezoff monkshood root 18-23 parts, Hippocampus japonicus 2-4 parts, cinnamon 8-15 parts, peach kernel 8-15 parts, campeachy wood 18-23 parts, asarum herb 4-8 parts, buthus martensi kirsch 8-13 parts, centipede 20-60 pieces, black-tail snake 15-22 parts, Eupolyphaga Sinensis Walker 7-15 parts, dipsacus root 15-25 parts, dragon's blood resin 9-15 parts, achyranthes and cyathula root 7-15 parts, black catechu 10-15 parts, borneol 7-15 parts, Clematis chinensis 17-22 parts, spatholobus stem 15-25 parts, sesame seed oil 200-300 parts, yellow lead 80-130 parts.

Description

technical field [0001] The invention relates to a medicine for external use, which can treat pain, numbness, swelling, inability to move, muscle spasm, and limb dysfunction caused by various diseases such as bone hyperplasia, cervical spondylosis, intervertebral disc herniation, and soft tissue injury. A plaster for treating cervical and lumbar diseases. Background technique [0002] Although the plasters currently on the market have certain curative effects, the selection of medicines is unreasonable, and the doses of medicines are relatively small, and can only treat a single disease. The onset of effect is slow, the course of treatment is long, the curative effect is low, and the price is high, so it is not suitable for the majority of patients. Contents of the invention [0003] The technical problem to be solved by the present invention is to provide a kind of plaster for treating cervical and lumbar diseases with quick onset, short treatment period, simple production...

AI Technical Summary

Problems solved by technology

[0002] Although the plasters currently on the market have a certain curative effect, the selection of drugs is unreasonable, the dose of the drug is too small, and it can only treat a single disease. The onset of effect is slow, the course of treatment is long, the curative effect is low, and the price is high.